STRA6 Antikörper (PE)
Kurzübersicht für STRA6 Antikörper (PE) (ABIN1712739)
Target
Alle STRA6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human STRA6
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- FCM(1:20-100)
-
Kommentare
-
Exitation/Emission: 480,565nm/578nm
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at 4°C
-
Haltbarkeit
- 12 months
-
-
- STRA6 (Stimulated By Retinoic Acid 6 (STRA6))
-
Andere Bezeichnung
- Stra6
-
Hintergrund
-
STRA6 is a 667 amino acid, multi-pass cell membrane protein. Stra6 functions as a cell-surface receptor for the complex retinol-retinol binding protein (RBP/RBP4). Ultimately increasing cellular retinol uptake from the retinol-RBP complex, Stra6 removes retinol from RBP/RPB4 and transports it across the plasma membrane, where it is metabolized. Stra6 is broadly expressed, with 4 named isoforms that exist as a result of alternative splicing events. Mutations in the gene encoding Stra6 cause Matthew-Wood Syndrome, also known as Spear Syndrome. This syndrome is characterized by anophtalmia, mild facial dysmorphism and malformations of the heart, lung and diaphragm. The Stra6 gene maps to chromosome 15q24.1.
Subcellular location: Extracellular
Synonyms: Stimulated by retinoic acid gene 6 protein homolog, STRA6_HUMAN. -
Gen-ID
- 64220
-
Pathways
- Feeding Behaviour
Target
-